{"entity":{"type":"insider","cik":"0001535289","url":"/insider/0001535289","json_url":"/insider/0001535289.json","name":"Spoor Johan M.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":14,"n_filings":11,"first":"2011-11-21","last":"2025-04-01","span_basis":"filed_date"},"name_variants":[{"name":"Spoor Johan M.","source":"filing","n_filings":11,"first_seen":"2011-11-21","last_seen":"2025-04-01"}],"transactions":[{"id":4872835,"accession":"0000950170-25-048775","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-048775","line_url":"/filing/0000950170-25-048775","is_derivative":false,"issuer_cik":"0000728387","issuer_name":"Perspective Therapeutics, Inc.","issuer_ticker":"CATX","issuer_name_source":null,"issuer_url":"/issuer/0000728387","owner_cik":"0001535289","owner_name":"Spoor Johan M.","owner_display_name":"Spoor Johan M.","owner_url":"/insider/0001535289","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":26676.0,"shares_display":"26,676","price_per_share":2.2369403058929374,"price_display":"2.24","price_state":"stated","total_value":59672.6196,"total_display":"59,672.62","total_whole":"59,673","shares_owned_after":59383.0,"shares_owned_after_display":"59,383","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-28","filed_date":"2025-04-01","scope":"insider","n_lines":2},{"id":2243297,"accession":"0000950170-24-133355","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-133355","line_url":"/filing/0000950170-24-133355#line-1","is_derivative":false,"issuer_cik":"0000728387","issuer_name":"Perspective Therapeutics, Inc.","issuer_ticker":"CATX","issuer_name_source":null,"issuer_url":"/issuer/0000728387","owner_cik":"0001535289","owner_name":"Spoor Johan M.","owner_display_name":"Spoor Johan M.","owner_url":"/insider/0001535289","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8000.0,"shares_display":"8,000","price_per_share":3.7665,"price_display":"3.77","price_state":"stated","total_value":30132.0,"total_display":"30,132.00","total_whole":"30,132","shares_owned_after":36257.0,"shares_owned_after_display":"36,257","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-04","filed_date":"2024-12-04","scope":"insider"},{"id":2903345,"accession":"0000950170-24-130754","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-24-130754","line_url":"/filing/0000950170-24-130754","is_derivative":false,"issuer_cik":"0000728387","issuer_name":"Perspective Therapeutics, Inc.","issuer_ticker":"CATX","issuer_name_source":null,"issuer_url":"/issuer/0000728387","owner_cik":"0001535289","owner_name":"Spoor Johan M.","owner_display_name":"Spoor Johan M.","owner_url":"/insider/0001535289","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":26500.0,"shares_display":"26,500","price_per_share":3.791245283018868,"price_display":"3.79","price_state":"stated","total_value":100468.0,"total_display":"100,468.00","total_whole":"100,468","shares_owned_after":152072.0,"shares_owned_after_display":"152,072","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-25","filed_date":"2024-11-26","scope":"insider","n_lines":3},{"id":2237145,"accession":"0000950170-24-073145","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-073145","line_url":"/filing/0000950170-24-073145#line-1","is_derivative":false,"issuer_cik":"0000728387","issuer_name":"Perspective Therapeutics, Inc.","issuer_ticker":"CATX","issuer_name_source":null,"issuer_url":"/issuer/0000728387","owner_cik":"0001535289","owner_name":"Spoor Johan M.","owner_display_name":"Spoor Johan M.","owner_url":"/insider/0001535289","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":1.1743,"price_display":"1.17","price_state":"stated","total_value":117430.0,"total_display":"117,430.00","total_whole":"117,430","shares_owned_after":137572.0,"shares_owned_after_display":"137,572","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-13","filed_date":"2024-06-13","scope":"insider"},{"id":8014883,"accession":"0001415889-19-000017","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-19-000017","line_url":"/filing/0001415889-19-000017#line-1","is_derivative":false,"issuer_cik":"0001535289","issuer_name":"AzurRx BioPharma, Inc.","issuer_ticker":"AZRX","issuer_name_source":null,"issuer_url":"/issuer/0001535289","owner_cik":"0001535289","owner_name":"Spoor Johan M.","owner_display_name":"Spoor Johan M.","owner_url":"/insider/0001535289","role":"Director, Officer (PRESIDENT AND CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":38583.0,"shares_display":"38,583","price_per_share":1.2951,"price_display":"1.30","price_state":"stated","total_value":49968.8433,"total_display":"49,968.84","total_whole":"49,969","shares_owned_after":338617.0,"shares_owned_after_display":"338,617","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-28","filed_date":"2019-01-02","scope":"insider"},{"id":7089012,"accession":"0001415889-14-000068","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-14-000068","line_url":"/filing/0001415889-14-000068#line-1","is_derivative":false,"issuer_cik":"0001402785","issuer_name":"FLUOROPHARMA MEDICAL, INC.","issuer_ticker":"FPMI","issuer_name_source":null,"issuer_url":"/issuer/0001402785","owner_cik":"0001535289","owner_name":"Spoor Johan M.","owner_display_name":"Spoor Johan M.","owner_url":"/insider/0001535289","role":"Director, Officer (CEO, PRESIDENT, CHAIRMAN)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO, PRESIDENT, CHAIRMAN","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.5,"price_display":"0.50","price_state":"stated","total_value":5000.0,"total_display":"5,000.00","total_whole":"5,000","shares_owned_after":200398.0,"shares_owned_after_display":"200,398","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-07","filed_date":"2014-01-08","scope":"insider"},{"id":3403036,"accession":"0001415889-12-001781","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-12-001781","line_url":"/filing/0001415889-12-001781#line-1","is_derivative":false,"issuer_cik":"0001402785","issuer_name":"FLUOROPHARMA MEDICAL, INC.","issuer_ticker":"FPMI","issuer_name_source":null,"issuer_url":"/issuer/0001402785","owner_cik":"0001535289","owner_name":"Spoor Johan M.","owner_display_name":"Spoor Johan M.","owner_url":"/insider/0001535289","role":"Director, Officer (CEO, PRESIDENT, CHAIRMAN)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO, PRESIDENT, CHAIRMAN","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.755,"price_display":"0.76","price_state":"stated","total_value":7550.0,"total_display":"7,550.00","total_whole":"7,550","shares_owned_after":190398.0,"shares_owned_after_display":"190,398","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-11-26","filed_date":"2012-11-27","scope":"insider"},{"id":2355722,"accession":"0001415889-12-001367","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-12-001367","line_url":"/filing/0001415889-12-001367#line-1","is_derivative":false,"issuer_cik":"0001402785","issuer_name":"FLUOROPHARMA MEDICAL, INC.","issuer_ticker":"FPMI","issuer_name_source":null,"issuer_url":"/issuer/0001402785","owner_cik":"0001535289","owner_name":"Spoor Johan M.","owner_display_name":"Spoor Johan M.","owner_url":"/insider/0001535289","role":"Director, Officer (CEO, PRESIDENT, CHAIRMAN)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO, PRESIDENT, CHAIRMAN","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":0.8,"price_display":"0.80","price_state":"stated","total_value":40000.0,"total_display":"40,000.00","total_whole":"40,000","shares_owned_after":130398.0,"shares_owned_after_display":"130,398","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-09-12","filed_date":"2012-09-12","scope":"insider"},{"id":2982923,"accession":"0001415889-12-001123","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-12-001123","line_url":"/filing/0001415889-12-001123#line-1","is_derivative":false,"issuer_cik":"0001402785","issuer_name":"FLUOROPHARMA MEDICAL, INC.","issuer_ticker":"FPMI","issuer_name_source":null,"issuer_url":"/issuer/0001402785","owner_cik":"0001535289","owner_name":"Spoor Johan M.","owner_display_name":"Spoor Johan M.","owner_url":"/insider/0001535289","role":"Director, Officer (CEO, PRESIDENT, CFO, CHAIRMAN)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO, PRESIDENT, CFO, CHAIRMAN","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":0.84,"price_display":"0.84","price_state":"stated","total_value":4200.0,"total_display":"4,200.00","total_whole":"4,200","shares_owned_after":80398.0,"shares_owned_after_display":"80,398","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-08-03","filed_date":"2012-08-03","scope":"insider"},{"id":3144569,"accession":"0001415889-12-000907","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-12-000907","line_url":"/filing/0001415889-12-000907#line-1","is_derivative":false,"issuer_cik":"0001402785","issuer_name":"FLUOROPHARMA MEDICAL, INC.","issuer_ticker":"FPMI","issuer_name_source":null,"issuer_url":"/issuer/0001402785","owner_cik":"0001535289","owner_name":"Spoor Johan M.","owner_display_name":"Spoor Johan M.","owner_url":"/insider/0001535289","role":"Director, Officer (CEO, PRESIDENT, CFO, CHAIRMAN)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO, PRESIDENT, CFO, CHAIRMAN","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6000.0,"shares_display":"6,000","price_per_share":0.82,"price_display":"0.82","price_state":"stated","total_value":4920.0,"total_display":"4,920.00","total_whole":"4,920","shares_owned_after":75398.0,"shares_owned_after_display":"75,398","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-06-15","filed_date":"2012-06-15","scope":"insider"},{"id":8951028,"accession":"0001415889-11-001329","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-11-001329","line_url":"/filing/0001415889-11-001329#line-1","is_derivative":false,"issuer_cik":"0001402785","issuer_name":"FLUOROPHARMA MEDICAL, INC.","issuer_ticker":"FPMI","issuer_name_source":null,"issuer_url":"/issuer/0001402785","owner_cik":"0001535289","owner_name":"Spoor Johan M.","owner_display_name":"Spoor Johan M.","owner_url":"/insider/0001535289","role":"Officer (CEO)","role_mark":"O","role_mark_label":"Officer (CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":1.0,"price_display":"1.00","price_state":"stated","total_value":5000.0,"total_display":"5,000.00","total_whole":"5,000","shares_owned_after":74398.0,"shares_owned_after_display":"74,398","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-11-18","filed_date":"2011-11-21","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":14,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":14,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":14},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000728387","name":"Perspective Therapeutics, Inc.","url":"/issuer/0000728387","role":"Director, Officer (Chief Executive Officer)","n_filings":4,"first_seen":"2024-06-13","last_seen":"2025-04-01"},{"type":"issuer","type_label":"ISSUER","cik":"0001604191","name":"AzurRx BioPharma, Inc.","url":"/issuer/0001604191","role":"Director, Officer (PRESIDENT AND CEO)","n_filings":1,"first_seen":"2019-01-02","last_seen":"2019-01-02"},{"type":"issuer","type_label":"ISSUER","cik":"0001402785","name":"FLUOROPHARMA MEDICAL, INC.","url":"/issuer/0001402785","role":"Director, Officer (CEO, PRESIDENT, CHAIRMAN)","n_filings":6,"first_seen":"2011-11-21","last_seen":"2014-01-08"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001535289","retrieved_at":"2026-08-22T19:34:56+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}